| 05/05/2026 3:51 PM | Chiesi Farmaceutici SpA (1464415) Filed by KalVista Pharmaceuticals (1348911) Subject | Form SC TO-C | |
| 05/01/2026 4:32 PM | KalVista Pharmaceuticals (1348911) Subject MILLENNIUM MANAGEMENT LLC (1273087) Filed by | Form SCHEDULE 13G/A | |
| 04/30/2026 3:35 PM | KalVista Pharmaceuticals (1348911) Filer | Form 10-KT/A | |
| 04/29/2026 7:30 AM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/20/2026 6:40 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 6:40 PM | KalVista Pharmaceuticals (1348911) Issuer Piekos Brian (1815308) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 6:41 PM | KalVista Pharmaceuticals (1348911) Issuer Sweeny Nicole (1827505) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 6:42 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 4:50 PM | KalVista Pharmaceuticals (1348911) Issuer Koh Bong Y (1615979) Reporting Shah Nimish P (1698082) Reporting Venrock Healthcare Capital Partners EG, L.P. (1808512) Reporting Venrock Healthcare Capital Partners III, L.P. (1738048) Reporting VHCP Co-Investment Holdings III, LLC (1750761) Reporting VHCP Management EG, LLC (1808518) Reporting VHCP Management III, LLC (1738053) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/25/2026 3:35 PM | KalVista Pharmaceuticals (1348911) Filer | Form 10-KT | |
| 03/25/2026 6:16 AM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KALV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/10/2026 5:47 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:44 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:42 PM | KalVista Pharmaceuticals (1348911) Issuer Piekos Brian (1815308) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:42 PM | KalVista Pharmaceuticals (1348911) Issuer Sweeny Nicole (1827505) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:43 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:44 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 6:44 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 6:44 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 6:45 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 4:00 PM | KalVista Pharmaceuticals (1348911) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 01/21/2026 3:09 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:10 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:10 PM | KalVista Pharmaceuticals (1348911) Issuer Piekos Brian (1815308) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:11 PM | KalVista Pharmaceuticals (1348911) Issuer Sweeny Nicole (1827505) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:11 PM | Arif Bilal (1959750) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 5:03 PM | KalVista Pharmaceuticals (1348911) Subject Point72 Asset Management, L.P. (1603466) Filed by | Form SCHEDULE 13G/A | |
| 01/12/2026 5:34 PM | KalVista Pharmaceuticals (1348911) Subject Point72 Asset Management, L.P. (1603466) Filed by | Form SCHEDULE 13G | |
| 01/08/2026 3:47 PM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/30/2025 3:28 PM | KalVista Pharmaceuticals (1348911) Subject MILLENNIUM MANAGEMENT LLC (1273087) Filed by | Form SCHEDULE 13G/A | |
| 12/09/2025 5:16 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/04/2025 3:02 PM | KalVista Pharmaceuticals (1348911) Issuer Sweeny Nicole (1827505) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 5:49 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 5:50 PM | KalVista Pharmaceuticals (1348911) Issuer Piekos Brian (1815308) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 5:46 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 5:47 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 3:07 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 3:11 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 3:11 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 3:13 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 3:45 PM | KalVista Pharmaceuticals (1348911) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
| 11/04/2025 4:21 PM | Frazier Life Sciences Public Fund, L.P. (1863769) Filed by KalVista Pharmaceuticals (1348911) Subject | Form SCHEDULE 13D/A | |
| 10/08/2025 5:58 PM | Arif Bilal (1959750) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 10/08/2025 5:59 PM | Arif Bilal (1959750) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/06/2025 6:15 AM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/02/2025 5:27 PM | KalVista Pharmaceuticals (1348911) Issuer Sensenig Bethany (1899935) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/02/2025 5:28 PM | KalVista Pharmaceuticals (1348911) Issuer Sensenig Bethany (1899935) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 5:28 PM | KalVista Pharmaceuticals (1348911) Issuer Unkart Edward W (1306267) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 5:29 PM | Fairey William (1727275) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 5:30 PM | KalVista Pharmaceuticals (1348911) Issuer Treanor Patrick (1929863) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 5:30 PM | KalVista Pharmaceuticals (1348911) Issuer Stuart Nancy (1594774) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 5:31 PM | KalVista Pharmaceuticals (1348911) Issuer Pereira Brian JG (1298146) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 6:15 AM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/29/2025 3:27 PM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 6:45 AM | KalVista Pharmaceuticals (1348911) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/11/2025 6:24 AM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/09/2025 6:02 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/26/2025 6:59 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/26/2025 7:00 PM | KalVista Pharmaceuticals (1348911) Issuer Sweeny Nicole (1827505) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/26/2025 6:57 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 8:33 PM | KalVista Pharmaceuticals (1348911) Issuer Sweeny Nicole (1827505) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/25/2025 8:33 PM | KalVista Pharmaceuticals (1348911) Issuer Sweeny Nicole (1827505) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 6:45 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 6:46 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 6:46 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 4:00 PM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/21/2025 3:35 PM | KalVista Pharmaceuticals (1348911) Filer | Form DEF 14A | |
| 08/21/2025 3:37 PM | KalVista Pharmaceuticals (1348911) Filer | Form DEFA14A | |
| 08/21/2025 3:39 PM | KalVista Pharmaceuticals (1348911) Filer | Form ARS | |
| 08/20/2025 4:20 PM | Frazier Life Sciences Public Fund, L.P. (1863769) Filed by KalVista Pharmaceuticals (1348911) Subject | Form SCHEDULE 13D/A | |
| 08/19/2025 3:26 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2025 3:27 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 4:29 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2025 7:50 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2025 7:56 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2025 3:27 PM | KalVista Pharmaceuticals (1348911) Filer | Form 424B5 | |
| 07/10/2025 6:13 AM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/07/2025 7:39 AM | KalVista Pharmaceuticals (1348911) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2025 6:27 PM | Audhya Paul K. (1860131) Reporting KalVista Pharmaceuticals (1348911) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2025 6:28 PM | KalVista Pharmaceuticals (1348911) Issuer Palleiko Benjamin L (1366244) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2025 6:28 PM | KalVista Pharmaceuticals (1348911) Issuer Yea Christopher (1691102) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2025 10:44 AM | Capital World Investors (1422849) Filed by KalVista Pharmaceuticals (1348911) Subject | Form SCHEDULE 13G/A | |